Related Experiment Video
Updated: Feb 17, 2026

09:17
Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
22.4K
An update on aging and dementia in Chile
Patricio Fuentes1, Cecilia Albala2
1Geriatrics Section, Medicine Department, Clinical University Hospital of Chile and Cognitive Neurology and Dementia Unit, Neurology Service, Hospital del Salvador, Santiago, Chile.
Dementia & Neuropsychologia
|December 8, 2017
Summary
Chile
Area of Science:
- Gerontology
- Public Health
- Neurology
Background:
- Chile's population is rapidly aging, with those over 60 comprising 15% of the total population.
- Economic development has outpaced social adaptation, straining health and social structures.
- Mental health issues in the elderly, particularly dementia, pose significant challenges.
Purpose of the Study:
- To update information on dementia prevalence within Chile's aging population.
- To assess the current landscape of dementia care and challenges in Chile.
Main Methods:
- Review of existing data on Chile's demographic transition and aging population.
- Analysis of dementia prevalence rates, especially in rural areas.
- Assessment of the current state of medical training, public awareness, and governmental response to dementia.
Main Results:
- Dementia prevalence exceeds 8% in individuals over 60, with higher rates in rural populations.
- Increased dementia awareness and medical training exist, but state support for patients and caregivers is insufficient.
- The number of elderly individuals in Chile has more than doubled between 1990 and 2014.
Conclusions:
- Chile faces significant challenges in addressing the growing needs of its aging population, particularly concerning dementia.
- There is a critical gap between awareness/training and the necessary state-level support systems for dementia care.
- Further research and policy development are needed to effectively manage dementia in the context of Chile's demographic shift.
Related Concept Videos
Aging
849
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
849
Dementia
584
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
584
Alzheimer's Disease: Overview
1.8K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.8K
Alzheimer's Disease: Treatment
1.0K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.0K
Pharmacodynamics in Geriatric Patients: Effects of Age
243
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
243
Drug Dosing: Geriatric Patients
286
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
286

